Nomad Power Solutions, Inc. (NMAD)
3.70
+0.09
(+2.49%)
USD |
NASDAQ |
Sep 21, 16:00
3.68
-0.02
(-0.54%)
After-Hours: 20:00
Nomad Power Solutions Enterprise Value : 45.16M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 45.16M |
| September 17, 2026 | 45.16M |
| September 16, 2026 | 43.31M |
| September 15, 2026 | 41.31M |
| September 14, 2026 | 39.92M |
| September 11, 2026 | 44.09M |
| September 10, 2026 | 46.71M |
| September 09, 2026 | 46.71M |
| September 08, 2026 | 48.94M |
| September 04, 2026 | 51.64M |
| September 03, 2026 | 45.86M |
| September 02, 2026 | 46.71M |
| September 01, 2026 | 52.72M |
| August 31, 2026 | 53.34M |
| August 28, 2026 | 55.96M |
| August 27, 2026 | 57.65M |
| August 26, 2026 | 53.95M |
| August 25, 2026 | 54.26M |
| August 24, 2026 | 53.49M |
| August 21, 2026 | 55.80M |
| August 20, 2026 | 54.42M |
| August 19, 2026 | 55.96M |
| August 18, 2026 | 54.57M |
| August 17, 2026 | 49.64M |
| August 14, 2026 | 51.95M |
| Date | Value |
|---|---|
| August 13, 2026 | 51.95M |
| August 12, 2026 | 50.10M |
| August 11, 2026 | 44.39M |
| August 10, 2026 | 50.10M |
| August 07, 2026 | 45.01M |
| August 06, 2026 | 50.87M |
| August 05, 2026 | 49.48M |
| August 04, 2026 | 47.17M |
| August 03, 2026 | 55.80M |
| July 31, 2026 | 58.58M |
| July 30, 2026 | 53.80M |
| July 29, 2026 | 51.49M |
| July 28, 2026 | 57.81M |
| July 27, 2026 | 58.12M |
| July 24, 2026 | 64.13M |
| July 23, 2026 | 64.59M |
| July 22, 2026 | 66.44M |
| July 21, 2026 | 72.92M |
| July 20, 2026 | 69.83M |
| July 17, 2026 | 78.77M |
| July 16, 2026 | 72.61M |
| July 15, 2026 | 80.16M |
| July 14, 2026 | 78.47M |
| July 13, 2026 | 76.46M |
| July 10, 2026 | 85.94M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.815B |
| Alnylam Pharmaceuticals, Inc. | 31.72B |
| Anika Therapeutics, Inc. | 265.34M |
| Savara, Inc. | 960.37M |
| Vericel Corp. | 1.980B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.344M |
| Total Expenses (Quarterly) | 2.187M |
| EPS Diluted (Quarterly) | -0.1623 |
| Earnings Yield | -27.04% |
| Normalized Earnings Yield | -26.48 |